Novo Nordisk A/S (NVO)
123.06
-0.96
(-0.77%)
USD |
NYSE |
May 03, 16:00
123.01
-0.05
(-0.04%)
After-Hours: 20:00
Novo Nordisk Gross Profit (TTM): 30.08B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 30.08B |
December 31, 2023 | 28.52B |
September 30, 2023 | 25.94B |
June 30, 2023 | 23.97B |
March 31, 2023 | 22.22B |
December 31, 2022 | 21.01B |
September 30, 2022 | 20.47B |
June 30, 2022 | 19.96B |
March 31, 2022 | 19.38B |
December 31, 2021 | 18.62B |
September 30, 2021 | 17.93B |
June 30, 2021 | 17.29B |
March 31, 2021 | 16.56B |
December 31, 2020 | 16.23B |
September 30, 2020 | 15.98B |
June 30, 2020 | 15.69B |
March 31, 2020 | 15.75B |
December 31, 2019 | 15.28B |
September 30, 2019 | 15.12B |
June 30, 2019 | 15.00B |
March 31, 2019 | 14.91B |
December 31, 2018 | 14.92B |
September 30, 2018 | 14.77B |
June 30, 2018 | 14.66B |
March 31, 2018 | 14.55B |
Date | Value |
---|---|
December 31, 2017 | 14.27B |
September 30, 2017 | 14.16B |
June 30, 2017 | 14.16B |
March 31, 2017 | 14.13B |
December 31, 2016 | 14.06B |
September 30, 2016 | 14.04B |
June 30, 2016 | 13.93B |
March 31, 2016 | 13.81B |
December 31, 2015 | 13.64B |
September 30, 2015 | 13.54B |
June 30, 2015 | 13.47B |
March 31, 2015 | 13.33B |
December 31, 2014 | 13.20B |
September 30, 2014 | 13.08B |
June 30, 2014 | 12.76B |
March 31, 2014 | 12.57B |
December 31, 2013 | 12.37B |
September 30, 2013 | 12.13B |
June 30, 2013 | 11.85B |
March 31, 2013 | 11.51B |
December 31, 2012 | 11.14B |
September 30, 2012 | 10.76B |
June 30, 2012 | 10.54B |
March 31, 2012 | 10.25B |
December 31, 2011 | 10.03B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
15.00B
Minimum
Jun 2019
30.08B
Maximum
Mar 2024
19.55B
Average
18.27B
Median
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Vertex Pharmaceuticals Inc | 8.607B |
Viking Therapeutics Inc | -- |
Evaxion Biotech AS | -- |
Moderna Inc | 2.061B |